Skip to main content
Two gloved hands with tweezers holding the PBTE cell engager for use in a scientific experiment.Blog posts

Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers

Key takeaways Researchers have examined how format-tuning bispecific T cell engagers (BTEs) boosts therapeutic efficacy against clear cell renal cell carcinoma (ccRCC). Using a novel persistent multivalent T cell engager (PMTE) to enhance cell avidity and tumor targeting, they tackle challenges like low plasma half-life, poor tumor retention, and antigen…
Andrea Candelli
29 January 2025
Close Menu